Alternative 5' exons of the CFTR gene show developmental regulation.

Hum Mol Genet

Paediatric Molecular Genetics, Weatherall Institute of Molecular Medicine, Oxford University, John Radcliffe Hospital, Oxford, OX3 9DS, UK.

Published: April 2003

The cystic fibrosis transmembrane conductance regulator (CFTR) gene shows a complex mechanism of tissue-specific and temporal regulation. Expression of the sheep and human CFTR genes shows a gradual decline during lung development, from the early mid-trimester through to term. Alternative upstream exons of CFTR have been identified in several species but their functional role remains obscure. We identified a novel 5' exon of the sheep CFTR gene (ov1a) that occurs in two splice forms (ov1aL and ov1aS), which are both mutually exclusive with exon 1. CFTR transcripts including ov1aL and ov1aS are present at low levels in many sheep tissues, however ov1aS shows temporal and spatial regulation during fetal lung development, being most abundant when CFTR expression levels start to decline. Alternative 5' exons -1a and 1a in the human CFTR gene also show changes in expression levels through lung development. Evaluation of ov1aL and ov1aS by Mfold reveals the potential to form extremely stable secondary structures which would cause ribosomal subunit detachment. Further, the loss of exon 1 from the CFTR transcript removes motifs that are crucial for normal trafficking of the CFTR protein. Recruitment of these alternative upstream exons may represent a novel mechanism of developmental regulation of CFTR expression.

Download full-text PDF

Source
http://dx.doi.org/10.1093/hmg/ddg079DOI Listing

Publication Analysis

Top Keywords

cftr gene
16
lung development
12
ov1al ov1as
12
cftr
11
alternative exons
8
exons cftr
8
developmental regulation
8
human cftr
8
alternative upstream
8
upstream exons
8

Similar Publications

Limb-girdle muscular dystrophy type 2E/R4 (LGMD2E/R4) is a rare disease that currently has no cure. It is caused by defects in the gene, mainly missense mutations, which cause the impairment of the sarcoglycan complex, membrane fragility, and progressive muscle degeneration. Here, we studied the fate of some β-sarcoglycan (β-SG) missense mutants, confirming that, like α-SG missense mutants, they are targeted for degradation through the ubiquitin-proteasome system.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores a new method for concentrating highly branched poly(β-amino ester) (HPAEs)/DNA nanoparticles for gene therapy aimed at treating cystic fibrosis, addressing challenges related to the high formulation concentrations required for clinical applications.
  • Researchers optimized a formulation using various buffers and achieved concentration through ultrafiltration, which significantly outperformed lyophilization by providing a 24-fold increase.
  • The concentrated formulation was effective in restoring CFTR protein production in lung epithelial cells, demonstrating better results than existing transfection reagents, highlighting its potential for future preclinical testing and clinical use.
View Article and Find Full Text PDF

The chloride transporter-channel SLC26A9 is mediated by a reciprocal regulatory mechanism through the interaction between its cytoplasmic STAS domain and the R domain of CFTR. In vertebrate Slc26a9s, the STAS domain structures are interrupted by a disordered loop which is conserved in mammals but is variable in non-mammals. Despite the numerous studies involving the STAS domains in SLC26 proteins, the role of the disordered loop region has not been identified.

View Article and Find Full Text PDF

G protein-coupled estrogen receptor 1 (GPER1) plays a crucial role in the progression of breast cancer and has emerged as a promising therapeutic target. However, while missense mutations in GPER1 have been detected in breast invasive carcinoma (BIC) samples, the resulting molecular, cellular and pharmacological changes remain unclear. The present study categorized BIC samples from The Cancer Genome Atlas database based on mutation information available in the cBioPortal database.

View Article and Find Full Text PDF

An update on multiple breath washout in children with cystic fibrosis.

Expert Rev Respir Med

December 2024

Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.

Introduction: Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the CF transmembrane regulator (CFTR) gene, leading to progressive lung disease and systemic complications. Lung disease remains the primary cause of morbidity and mortality, making early detection of lung function decline crucial. The Lung Clearance Index (LCI), derived from the multiple breath washout (MBW) test, has emerged as a sensitive measure for identifying early airway disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!